168 related articles for article (PubMed ID: 11493337)
1. Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation.
Selim AA; El-Ayat G; Wells CA
Histopathology; 2001 Aug; 39(2):198-202. PubMed ID: 11493337
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
Mazoujian G
Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors.
Selim AG; El-Ayat G; Wells CA
J Clin Pathol; 2002 Jan; 55(1):14-6. PubMed ID: 11825917
[TBL] [Abstract][Full Text] [Related]
5. Histiocytoid breast carcinoma: histological, immunohistochemical, ultrastructural, cytological and clinicopathological studies.
Shimizu S; Kitamura H; Ito T; Nakamura T; Fujisawa J; Matsukawa H
Pathol Int; 1998 Jul; 48(7):549-56. PubMed ID: 9701019
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G
APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
[TBL] [Abstract][Full Text] [Related]
7. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
Satoh F; Umemura S; Osamura RY
Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
[TBL] [Abstract][Full Text] [Related]
9. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
10. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
Collette J; Hendrick JC; Jaspar JM; Franchimont P
Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
[TBL] [Abstract][Full Text] [Related]
11. Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins.
Quinn CM; Ostrowski JL; Harkins L; Rice AJ; Loney DP
Histopathology; 1998 Dec; 33(6):531-6. PubMed ID: 9870147
[TBL] [Abstract][Full Text] [Related]
12. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.
Pagani A; Sapino A; Eusebi V; Bergnolo P; Bussolati G
Virchows Arch; 1994; 425(5):459-65. PubMed ID: 7850069
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
Mazoujian G; Pinkus GS; Davis S; Haagensen DE
Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702
[TBL] [Abstract][Full Text] [Related]
14. Gross cystic disease fluid protein-15 reactivity in extramammary Paget's disease with and without associated internal malignancy.
Kohler S; Smoller BR
Am J Dermatopathol; 1996 Apr; 18(2):118-23. PubMed ID: 8739985
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
Ansai S; Koseki S; Hozumi Y; Kondo S
Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
[TBL] [Abstract][Full Text] [Related]
16. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ
J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365
[TBL] [Abstract][Full Text] [Related]
17. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
Raju U; Ma CK; Shaw A
Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
[TBL] [Abstract][Full Text] [Related]
18. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary.
Monteagudo C; Merino MJ; LaPorte N; Neumann RD
Hum Pathol; 1991 Apr; 22(4):368-72. PubMed ID: 2050370
[TBL] [Abstract][Full Text] [Related]
19. Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.
Mack L; Kerkvliet N; Doig G; O'Malley FP
Hum Pathol; 1997 Aug; 28(8):974-9. PubMed ID: 9269835
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast.
Gupta D; Croitoru CM; Ayala AG; Sahin AA; Middleton LP
Ann Diagn Pathol; 2002 Jun; 6(3):141-7. PubMed ID: 12089723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
